thalidomide has been researched along with methylprednisolone in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baumgartner, WA; Herskowitz, A; Reitz, BA; Tamura, F; Vogelsang, GB | 1 |
| Volc-Platzer, B; Wolff, K | 1 |
| Federman, DG; Federman, GL | 1 |
| Lambert, J; Meuleman, L; Nijsten, T; Schroyens, W | 1 |
| Brito-Babapulle, F; Fielden, J; Rechner, I | 1 |
| Alvares, CL; Davies, FE; Dines, S; Ethell, ME; Horton, C; Jenner, MW; Krishnan, B; McCormack, R; Morgan, GJ; Potter, MN; Saso, R; Treleaven, JG; Wu, P | 1 |
| Chen, SL; Hu, Y; Li, X; Zhang, JJ; Zhong, YP | 1 |
| Erdel, M; Fiegl, M; Kilga-Nogler, S; Köck, L; Schennach, H; Sun, WL; Walder, A | 1 |
| Chalmers, RJ; Reddick, CL; Singh, MN | 1 |
| Suzuki, K | 1 |
| Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K | 1 |
| Cai, JF; Chen, Y; Guan, JL; Hua, YQ; Ma, HF; Shen, Y; Zou, J | 1 |
| Ainley, L; Chavda, SJ; Cheesman, S; Counsell, N; Horder, J; Kyriakou, C; Lee, L; Mehta, A; Newrick, F; Papanikolaou, X; Popat, R; Rabin, N; Sive, J; Wechalekar, A; Yong, K | 1 |
| Da, Z; Li, X; Lu, Z; Su, D | 1 |
| Jiang, L; Li, W; Qiu, X; Yuan, P | 1 |
| He, J; Liu, T; Xiao, X; Zhou, W | 1 |
2 review(s) available for thalidomide and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion.
Topics: Aged; Amyloidosis; Bence Jones Protein; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Immunoglobulin Light-chain Amyloidosis; Kidney; Lenalidomide; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Pyrazines; Renal Insufficiency; Thalidomide | 2012 |
1 trial(s) available for thalidomide and methylprednisolone
| Article | Year |
|---|---|
[Bortezomib combined with other drugs for treating 60 cases of multiple myeloma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Pyrazines; Thalidomide; Treatment Outcome | 2009 |
17 other study(ies) available for thalidomide and methylprednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine.
Topics: Animals; Cyclosporins; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunosuppression Therapy; Male; Methylprednisolone; Rats; Rats, Inbred Lew; Thalidomide; Transplantation, Homologous | 1990 |
[Treatment of subacute cutaneous lupus erythematosus with thalidomide].
Topics: Azathioprine; Biopsy; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Immunoglobulin M; Kidney; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Skin; Thalidomide | 1983 |
Recalcitrant pyoderma gangrenosum treated with thalidomide.
Topics: Anti-Inflammatory Agents; Dermatologic Agents; Humans; Male; Methylprednisolone; Middle Aged; Pyoderma Gangrenosum; Recurrence; Thalidomide; Treatment Failure; Treatment Outcome | 2000 |
Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisolone.
Topics: Aged; Anti-Inflammatory Agents; Drug Eruptions; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Multiple Myeloma; Thalidomide | 2002 |
Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capillary Leak Syndrome; Combined Modality Therapy; Critical Care; Cyclophosphamide; Dexamethasone; Doxorubicin; Dyspnea; Edema; Fasciitis, Necrotizing; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Models, Biological; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Thalidomide; Vasculitis, Leukocytoclastic, Cutaneous; Vincristine | 2003 |
The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide - vincristine - doxorubicin - methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-
Topics: Adult; Aged; Antineoplastic Agents; Case-Control Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Vincristine | 2006 |
Successful treatment of MDS with lenalidomide, complicated by transient autoimmune hemolysis.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Female; Humans; Immunoglobulins; Lenalidomide; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Thalidomide; Treatment Outcome | 2010 |
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Comorbidity; Cyclosporine; Dapsone; Hidradenitis Suppurativa; Humans; Infliximab; Male; Methylprednisolone; Middle Aged; Minocycline; Prednisolone; Pyoderma Gangrenosum; Thalidomide; Treatment Outcome | 2010 |
Myeloma presenting during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous | 2014 |
Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.
Topics: Antirheumatic Agents; Behcet Syndrome; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Pneumonia; Thalidomide | 2017 |
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Progression-Free Survival; Salvage Therapy; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Young Adult | 2021 |
LABD-like manifestation in a patient with systemic lupus erythematosus.
Topics: Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Linear IgA Bullous Dermatosis; Lupus Erythematosus, Systemic; Methylprednisolone; Severity of Illness Index; Thalidomide; Young Adult | 2021 |
Post-cesarean section pemphigus vegetans in a young woman treated with methylprednisolone and thalidomide.
Topics: Autoimmune Diseases; Cesarean Section; Female; Humans; Methylprednisolone; Pemphigus; Pregnancy; Thalidomide | 2021 |
Refractory Behçet's disease treated with low-dose interleukin-2: A case report.
Topics: Adult; Behcet Syndrome; Erythema Nodosum; Female; Humans; Hydroxychloroquine; Interleukin-2; Methylprednisolone; Oral Ulcer; Thalidomide | 2022 |